Lessons from Genetically Altered Mesenchymal Stem Cells (MSCs): Candidates for Improved MSC-Directed Myocardial Repair

Cell Transplantation

Volumn 21, Issue 6, 2012, Pages 1065-1074

  Alfaro, Maria P ^a   Young, Pampee P ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell biology; Mesenchymal stem cells (MSCs); Self renewal; Transplantation

Indexed keywords

CELL DIFFERENTIATION; CELL HOMING; CELL REGENERATION; CELL RENEWAL; CELL SURVIVAL; ENGRAFTMENT; GENETIC ENGINEERING; HEART INFARCTION; HEART MUSCLE; HUMAN; IMMUNOMODULATION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; THERAPY EFFECT; TISSUE CULTURE; WOUND HEALING;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; PARACRINE COMMUNICATION;

EID: 84865453686     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X612477     Document Type: Review

References (83)

1. Akkina, R. K.; Walton, R. M.; Chen, M. L.; Li, Q. X.; Planelles, V.; Chen, I. S. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70: 2581-2585; 1996.
2. Alfaro, M. P.; Pagni, M.; Vincent, A.; Atkinson, J.; Hill, M. F.; Cates, J.; Davi dson, J. M.; Rottman, J.; Lee, E.; Young, P. P. The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc. Natl. Acad. Sci. USA 105:18366-18371; 2008.
3. Alfaro, M. P.; Vincent, A.; Saraswati, S.; Thorne, C. A.; Hong, C. C.; Lee, E.; Young, P. P. sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. J. Biol. Chem. 285:35645-35653; 2010.
4. Alvarez-Dolado, M.; Pardal, R.; Garcia-Verdugo, J. M.; Fike, J. R.; Lee, H. O.; Pfeffer, K.; Lois, C.; Morrison, S. J.; Alvarez-Buylla, A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425:968-973; 2003.
5. Baddoo, M.; Hill, K.; Wilkinson, R.; Gaupp, D.; Hughes, C.; Kopen, G. C.; Phinney, D. G. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J. Cell. Biochem. 89:1235-1249; 2003.
6. Behfar, A.; Terzic, A. Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1): S78-82; 2006.
7. Behfar, A.; Yamada, S.; Crespo-Diaz, R.; Nesbitt, J. J.; Rowe, L. A.; Perez-Terzic, C.; Gaussin, V.; Homsy, C.; Bartunek, J.; Terzic, A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J. Am. Coll. Cardiol. 56:721-734; 2010.
8. Blaese, R. M.; Culver, K. W.; Chang, L.; Anderson, W. F.; Mullen, C.; Nienhuis, A.; Carter, C.; Dunbar, C.; Leitman, S.; Berger, M.; Miller, A. D.; Morgan, R.; Fleisher, T.; Kobyashi, R.; Kobyashi, A. L.; Klein, H.; Shearer, G.; Clerici, M.; McGarrity, G. Cassell, A. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992. Hum. Gene Ther. 4:521-527; 1993.
9. Calloni, G. W.; Glavieux-Pardanaud, C.; Le Douarin, N. M.; Dupin, E. Sonic hedgehog promotes the development of multipotent neural crest progenitors endowed with both mesenchymal and neural potentials. Proc. Natl. Acad. Sci. USA 104:19879-19884; 2007.
10. Cassani, B.; Montini, E.; Maruggi, G.; Ambrosi, A.; Mirolo, M.; Selleri, S.; Biral, E.; Frugnoli, I.; Hernandez-Trujillo, V.; Di Serio, C.; Roncarolo, M. G.; Naldini, L.; Mavilio, F.; Aiuti, A. Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy. Blood 114:3546-3556; 2009.
11. Chen, Y.; Xiang, L. X.; Shao, J. Z.; Pan, R. L.; Wang, Y. X.; Dong, X. J.; Zhang, G. R. Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver. J. Cell. Mol. Med. 14:1494-1508; 2010.
12. Colter, D. C.; Class, R.; DiGirolamo, C. M.; Prockop, D. J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc. Natl. Acad. Sci. USA 97:3213-3218; 2000.
13. Copland, I. B.; Jolicoeur, E. M.; Gillis, M. A.; Cuerquis, J.; Eliopoulos, N.; Annabi, B.; Calderone, A.; Tanguay, J. F.; Ducharme, A.; Galipeau, J. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties. Cardiovasc. Res. 79:405-415; 2008.
14. Crisan, M.; Yap, S.; Casteilla, L.; Chen, C. W.; Corselli, M.; Park, T. S.; Andriolo, G.; Sun, B.; Zheng, B.; Zhang, L.; Norotte, C.; Teng, P. N.; Traas, J.; Schugar, R.; Deasy, B. M.; Badylak, S.; Buhring, H. J.; Giacobino, J. P.; Lazzari, L.; Huard, J.; Peault, B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301-313; 2008.
15. Dai, J.; Keller, J.; Zhang, J.; Lu, Y.; Yao, Z.; Keller, E. T. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res. 65:8274-8285; 2005.
16. da Silva Meirelles, L.; Caplan, A. I.; Nardi, N. B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26: 2287-2299; 2008.
17. Delorme, B.; Ringe, J.; Gallay, N.; Le Vern, Y.; Kerboeuf, D.; Jorgensen, C.; Rosset, P.; Sensebe, L.; Layrolle, P.; Haupl, T.; Charbord, P. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 111:2631-2635; 2008.
18. Devine, M. J.; Mierisch, C. M.; Jang, E.; Anderson, P. C.; Balian, G. Transplanted bone marrow cells localize to fracture callus in a mouse model. J. Orthop. Res. 20: 1232-1239; 2002.
19. Dimitriou, H.; Perdikogianni, C.; Martimianaki, G.; Choumerianou, D. M.; Pelagiadis, J.; Kalmanti, M. Are mesenchymal stromal cells from children resistant to apoptosis? Cell Prolif. 42:276-283; 2009.
20. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317; 2006.
21. Dupin, E.; Calloni, G. W.; Le Douarin, N. M. The cephalic neural crest of amniote vertebrates is composed of a large majority of precursors endowed with neural, melanocytic, chondrogenic and osteogenic potentialities. Cell Cycle 9:238-249; 2010.
22. Gronthos, S.; Graves, S. E.; Ohta, S.; Simmons, P. J. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 84:4164-4173; 1994.
23. Haas, D. L.; Case, S. S.; Crooks, G. M.; Kohn, D. B. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol. Ther. 2:71-80; 2000.
24. Hakuno, D.; Fukuda, K.; Makino, S.; Konishi, F.; Tomita, Y.; Manabe, T.; Suzuki, Y.; Umezawa, A.; Ogawa, S. Bone marrow-derived regenerated cardiomyocytes (CMG cells) express functional adrenergic and muscarinic receptors. Circulation 105:380-386; 2002.
25. Halfon, S.; Abramov, N.; Grinblat, B.; Ginis, I. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev. 20: 53-66; 2010.
26. Hare, J. M.; Traverse, J. H.; Henry, T. D.; Dib, N.; Strumpf, R. K.; Schulman, S. P.; Gerstenblith, G.; DeMaria, A. N.; Denktas, A. E.; Gammon, R. S.; Hermiller, Jr., J. B.; Reisman, M. A.; Schaer, G. L.; Sherman, W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54:2277-2286; 2009.
27. Harris, D. T. Cord blood stem cells: A review of potential neurological applications. Stem Cell Rev. 4:269-274; 2008.
28. Heeschen, C.; Aicher, A.; Lehmann, R.; Fichtlscherer, S.; Vasa, M.; Urbich, C.; Mildner-Rihm, C.; Martin, H.; Zeiher, A. M.; Dimmeler, S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102:1340-1346; 2003.
29. Horwitz, E. M.; Gordon, P. L.; Koo, W. K.; Marx, J. C.; Neel, M. D.; McNall, R. Y.; Muul, L.; Hofmann, T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc. Natl. Acad. Sci. USA 99:8932-8937; 2002.
30. Hung, S. C.; Pochampally, R. R.; Hsu, S. C.; Sanchez, C.; Chen, S. C.; Spees, J.; Prockop, D. J. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS ONE 2:e416; 2007.
31. Iso, Y.; Spees, J. L.; Serrano, C.; Bakondi, B.; Pochampally, R.; Song, Y. H.; Sobel, B. E.; Delafontaine, P.; Prockop, D. J. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem. Biophys. Res. Commun. 354: 700-706; 2007.
32. Jiang, S.; Haider, H.; Idris, N. M.; Salim, A.; Ashraf, M. Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ. Res. 99:776-784; 2006.
33. John, N.; Cinelli, P.; Wegner, M.; Sommer, L. TGFbetamediated Sox10 suppression controls mesenchymal progenitor generation in neural crest stem cells. Stem Cells 29:689-699; 2011.
34. Jones, E.; English, A.; Churchman, S. M.; Kouroupis, D.; Boxall, S. A.; Kinsey, S.; Giannoudis, P. G.; Emery, P.; McGonagle, D. Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. Arthritis Rheum. 62: 1944-1954; 2010.
35. Kinnaird, T.; Stabile, E.; Burnett, M. S.; Lee, C. W.; Barr, S.; Fuchs, S.; Epstein, S. E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94:678-685; 2004.
36. Le Douarin, N. M.; Calloni, G. W.; Dupin, E. The stem cells of the neural crest. Cell Cycle 7:1013-1019; 2008.
37. Liu, X. B.; Jiang, J.; Gui, C.; Hu, X. Y.; Xiang, M. X.; Wang, J. A. Angiopoietin-1 protects mesenchymal stem cells against serum deprivation and hypoxia-induced apoptosis through the PI3K/Akt pathway. Acta Pharmacol. Sin. 29:815-822; 2008.
38. Lu, C.; Li, X. Y.; Hu, Y.; Rowe, R. G.; Weiss, S. J. MT1MMP controls human mesenchymal stem cell trafficking and differentiation. Blood 115:221-229; 2010.
39. Madonna, R.; Geng, Y. J.; De Caterina, R. Adipose tissue-derived stem cells: Characterization and potential for cardiovascular repair. Arterioscler. Thromb. Vasc. Biol. 29: 1723-1729; 2009.
40. Makino, S.; Fukuda, K.; Miyoshi, S.; Konishi, F.; Kodama, H.; Pan, J.; Sano, M.; Takahashi, T.; Hori, S.; Abe, H.; Hata, J.; Umezawa, A.; Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103:697-705; 1999.
41. Mangi, A. A.; Noiseux, N.; Kong, D.; He, H.; Rezvani, M.; Ingwall, J. S.; Dzau, V. J. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9:1195-1201; 2003.
42. Matsumoto, R.; Omura, T.; Yoshiyama, M.; Hayashi, T.; Inamoto, S.; Koh, K. R.; Ohta, K.; Izumi, Y.; Nakamura, Y.; Akioka, K.; Kitaura, Y.; Takeuchi, K.; Yoshikawa, J. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 25:1168-1173; 2005.
43. Meirelles Lda, S.; Nardi, N. B. Murine marrow-derived mesenchymal stem cell: Isolation, in vitro expansion, and characterization. Br. J. Haematol. 123:702-711; 2003.
44. Mirotsou, M.; Zhang, Z.; Deb, A.; Zhang, L.; Gnecchi, M.; Noiseux, N.; Mu, H.; Pachori, A.; Dzau, V. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc. Natl. Acad. Sci. USA 104: 1643-1648; 2007.
45. Moscow, J. A.; Huang, H.; Carter, C.; Hines, K.; Zujewski, J.; Cusack, G.; Chow, C.; Venzon, D.; Sorrentino, B.; Chiang, Y.; Goldspiel, B.; Leitman, S.; Read, E. J.; Abati, A.; Gottesman, M. M.; Pastan, I.; Sellers, S.; Dunbar, C.; Cowan, K. H. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood 94:52-61; 1999.
46. Orlic, D.; Kajstura, J.; Chimenti, S.; Jakoniuk, I.; Anderson, S. M.; Li, B.; Pickel, J.; McKay, R.; Nadal-Ginard, B.; Bodine, D. M.; Leri, A.; Anversa, P. Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705; 2001.
47. Ortiz, L. A.; Dutreil, M.; Fattman, C.; Pandey, A. C.; Torres, G.; Go, K.; Phinney, D. G. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl. Acad. Sci. USA 104:11002-11007; 2007.
48. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
49. Pozzobon, M.; Ghionzoli, M.; De Coppi, P. ES, iPS, MSC, and AFS cells. Stem cells exploitation for pediatric surgery: Current research and perspective. Pediatr. Surg. Int. 26:3-10; 2010.
50. Reese, J. S.; Koc, O. N.; Lee, K. M.; Liu, L.; Allay, J. A.; Phillips, Jr., W. P.; Gerson, S. L. Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea. Proc. Natl. Acad. Sci. USA 93:14088-14093; 1996.
51. Rombouts, W. J.; Ploemacher, R. E. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 17:160-170; 2003.
52. Satija, N. K.; Gurudutta, G. U.; Sharma, S.; Afrin, F.; Gupta, P.; Verma, Y. K.; Singh, V. K.; Tripathi, R. P. Mesenchymal stem cells: Molecular targets for tissue engineering. Stem Cells Dev. 16:7-23; 2007.
53. Shake, J. G.; Gruber, P. J.; Baumgartner, W. A.; Senechal, G.; Meyers, J.; Redmond, J. M.; Pittenger, M. F.; Martin, B. J. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann. Thorac. Surg. 73:1919-1925; discussion 1926; 2002.
54. Shen, F. H.; Visger, J. M.; Balian, G.; Hurwitz, S. R.; Diduch, D. R. Systemically administered mesenchymal stromal cells transduced with insulin-like growth factor-I localize to a fracture site and potentiate healing. J. Orthop. Trauma 16:651-659; 2002.
55. Shi, M.; Li, J.; Liao, L.; Chen, B.; Li, B.; Chen, L.; Jia, H.; Zhao, R. C. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: Role in homing efficiency in NOD/SCID mice. Haematologica 92:897-904; 2007.
56. Shi, S.; Gronthos, S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J. Bone Miner. Res. 18:696-704; 2003.
57. Shi, Y.; Hu, G.; Su, J.; Li, W.; Chen, Q.; Shou, P.; Xu, C.; Chen, X.; Huang, Y.; Zhu, Z.; Huang, X.; Han, X.; Xie, N.; Ren, G. Mesenchymal stem cells: A new strategy for immunosuppression and tissue repair. Cell Res. 20: 510-518; 2010.
58. Shirozu, M.; Tada, H.; Tashiro, K.; Nakamura, T.; Lopez, N. D.; Nazarea, M.; Hamada, T.; Sato, T.; Nakano, T.; Honjo, T. Characterization of novel secreted and membrane proteins isolated by the signal sequence trap method. Genomics 37:273-280; 1996.
59. Short, B.; Brouard, N.; Occhiodoro-Scott, T.; Ramakrishnan, A.; Simmons, P. J. Mesenchymal stem cells. Arch. Med. Res. 34:565-571; 2003.
60. Simmons, P. J.; Torok-Storb, B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78:55-62; 1991.
61. Son, B. R.; Marquez-Curtis, L. A.; Kucia, M.; Wysoczynski, M.; Turner, A. R.; Ratajczak, J.; Ratajczak, M. Z.; Janowska-Wieczorek, A. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-cmet axes and involves matrix metalloproteinases. Stem Cells 24:1254-1264; 2006.
62. Sweeney, S. M.; Orgel, J. P.; Fertala, A.; McAuliffe, J. D.; Turner, K. R.; Di Lullo, G. A.; Chen, S.; Antipova, O.; Perumal, S.; Ala-Kokko, L.; Forlino, A.; Cabral, W. A.; Barnes, A. M.; Marini, J. C.; San Antonio, J. D. Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J. Biol. Chem. 283:21187-21197; 2008.
63. Tang, Y. L.; Zhao, Q.; Zhang, Y. C.; Cheng, L.; Liu, M.; Shi, J.; Yang, Y. Z.; Pan, C.; Ge, J.; Phillips, M. I. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul. Pept. 117:3-10; 2004.
64. Tavian, M.; Zheng, B.; Oberlin, E.; Crisan, M.; Sun, B.; Huard, J.; Peault, B. The vascular wall as a source of stem cells. Ann. NY Acad. Sci. 1044:41-50; 2005.
65. Tolar, J.; Le Blanc, K.; Keating, A.; Blazar, B. R. Concise review: Hitting the right spot with mesenchymal stromal cells. Stem Cells 28:1446-1455; 2010.
66. Tropel, P.; Noél, D.; Platet, N.; Legrand, P.; Benabid, A.L.; Berger, F. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp. Cell Res. 295:395-406; 2004.
67. Tsubokawa, T.; Yagi, K.; Nakanishi, C.; Zuka, M.; Nohara, A.; Ino, H.; Fujino, N.; Konno, T.; Kawashiri, M. A.; Ishibashi-Ueda, H.; Nagaya, N.; Yamagishi, M. Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. Am. J. Physiol. Heart Circ. Physiol. 298:H1320-1329; 2010.
68. Uemura, R.; Xu, M.; Ahmad, N.; Ashraf, M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98: 1414-1421; 2006.
69. Uren, A.; Reichsman, F.; Anest, V.; Taylor, W. G.; Muraiso, K.; Bottaro, D. P.; Cumberledge, S.; Rubin, J. S. Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J. Biol. Chem. 275:4374-4382; 2000.
70. U.S. National Library of Medicine, U.S. National Institutes of Health, U.S. Department of Health & Human Services. ClinicalTrials.gov.http://clinicaltrials.gov/ct2/home
71. van der Meer, P.; Voors, A. A.; Lipsic, E.; van Gilst, W. H.; van Veldhuisen, D. J. Erythropoietin in cardiovascular diseases. Eur. Heart J. 25:285-291; 2004.
72. Viswanathan, A.; Painter, R. G.; Lanson, Jr., N. A.; Wang, G. Functional expression of N-formyl peptide receptors in human bone marrow-derived mesenchymal stem cells. Stem Cells 25:1263-1269; 2007.
73. Volarevic, V.; Arsenijevic, N.; Lukic, M. L.; Stojkovic, M. Mesenchymal stem cell treatment of complications of diabetes mellitus. Stem Cells 29(1):5-10; 2011.
74. Wang, Y.; Deng, Y.; Zhou, G. Q. SDF-1alpha/CXCR4mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 1195:104-112; 2008.
75. Wang, Y. Q.; Wang, M.; Zhang, P.; Song, J. J.; Li, Y. P.; Hou, S. H.; Huang, C. X. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction. Chin. Med. J. (Engl.) 121:2290-2298; 2008.
76. Wei, C. L.; Miura, T.; Robson, P.; Lim, S. K.; Xu, X. Q.; Lee, M. Y.; Gupta, S.; Stanton, L.; Luo, Y.; Schmitt, J.; Thies, S.; Wang, W.; Khrebtukova, I.; Zhou, D.; Liu, E. T.; Ruan, Y. J.; Rao, M.; Lim, B. Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state. Stem Cells 23: 166-185; 2005.
77. Westrich, J.; Yaeger, P.; He, C.; Stewart, J.; Chen, R.; Seleznik, G.; Larson, S.; Wentworth, B.; O'Callaghan, M.; Wadsworth, S.; Akita, G.; Molnar, G. Factors affecting residence time of mesenchymal stromal cells (MSC) injected into the myocardium. Cell Transplant. 19: 937-948; 2010.
78. Whelan, R. S.; Kaplinskiy, V.; Kitsis, R. N. Cell death in the pathogenesis of heart disease: Mechanisms and significance. Annu. Rev. Physiol. 72:19-44; 2010.
79. Xu, S.; De Becker, A.; Van Camp, B.; Vanderkerken, K.; Van Riet, I. An improved harvest and in vitro expansion protocol for murine bone marrow-derived mesenchymal stem cells. J. Biomed. Biotechnol. 2010:105940; 2010.
80. Yagi, H.; Soto-Gutierrez, A.; Parekkadan, B.; Kitagawa, Y.; Tompkins, R. G.; Kobayashi, N.; Yarmush, M. L. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant. 19:667-679; 2010.
81. Yoon, Y. S.; Wecker, A.; Heyd, L.; Park, J. S.; Tkebuchava, T.; Kusano, K.; Hanley, A.; Scadova, H.; Qin, G.; Cha, D. H.; Johnson, K. L.; Aikawa, R.; Asahara, T.; Losordo, D. W. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115:326-338; 2005.
82. Zappia, E.; Casazza, S.; Pedemonte, E.; Benvenuto, F.; Bonanni, I.; Gerdoni, E.; Giunti, D.; Ceravolo, A.; Cazzanti, F.; Frassoni, F.; Mancardi, G.; Uccelli, A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-1761; 2005.
83. Zhang, X.; Hirai, M.; Cantero, S.; Ciubotariu, R.; Dobrila, L.; Hirsh, A.; Igura, K.; Satoh, H.; Yokomi, I.; Nishimura, T.; Yamaguchi, S.; Yoshimura, K.; Rubinstein, P.; Takahashi, T. A. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: Reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J. Cell. Biochem. 112:1206-1218; 2011.